“End-to-End” Strategies Achieve Better Enrollment, Diversity, and Data Collection in Clinical Trials
The revolution in cancer drug development has a caveat: Only a fraction of eligible patients take part in clinical trials. Historically, findings from studies estimate that the share of eligible ...
When implementing disability-inclusive practices, governments should consider several key factors, as illustrated through a federal request for information (RFI), and in a new local data standard. The ...
Initiatives that encourage or mandate collecting LGBTQ+ data could provide a plethora of benefits for clinicians and health care providers, from identifying disparities to creating stronger, more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback